Serum fibroblast growth factor 21 levels in polycystic ovary syndrome

Gorar, Suheyla; Culha, Cavit; Uc, Ziynet; Dellal, Fatma; Serter, Rüştü; Aral, Sema; Aral, Yalcin

doi:10.3109/09513590.2010.487587

Serum fibroblast growth factor 21 levels in polycystic ovary syndrome

Atıf İçin Kopyala

Gorar S., Culha C., Uc Z. A. , Dellal F. D. , Serter R. , Aral S., et al.

GYNECOLOGICAL ENDOCRINOLOGY, cilt.26, ss.819-826, 2010 (SCI İndekslerine Giren Dergi)

Cilt numarası: 26 Konu: 11
Basım Tarihi: 2010
Doi Numarası: 10.3109/09513590.2010.487587
Dergi Adı: GYNECOLOGICAL ENDOCRINOLOGY
Sayfa Sayısı: ss.819-826

Özet

Aim. This study was designed to measure serum fibroblast growth factor 21 (FGF21) levels in patients with polycystic ovary syndrome (PCOS) and healthy subjects.